Quanta Dialysis Technologies reached the limits of its capacity to address the home dialysis market not long after the US Food and Drug Administration cleared its SC+ portable home-based dialysis system in December of 2020.
Now that the device is FDA-cleared and has a CE mark for hospital, clinical and home indications, the company shifted its attention to building up